Pharmaceutical Industry Roundtable

2nd edition, November 21th, 2013, Cismigiu Hotel, Lipscani Hall

ATTENDANCE BY INVITATION ONLY

As Romania has committed on a program of repaying debts to the pharma industry, what will be the impact on this sector?

The pharma industry is set to post only a slight growth in Romania, given the reduced availability of medical services for patients and the negative impact of the claw back tax. Producers are also calling for a redesign of the claw-back mechanism, urging that it should take into account only the producer price.

Find out about upcoming legislation changes and how they will affect the pharma industry at the second edition of Pharmaceutical Roundtable.

 

Program

IMG_7505 IMG_7504 IMG_7509
IMG_7517 IMG_7516 IMG_7530
IMG_7538 IMG_7542 IMG_7532

 

 

15.00 – 15.30 Registration

15:30 – 15:45 Welcome address: Valeriu Stoica, Founding Partner, STOICA & Asociaţii

 15.45 – 17.30 Panel discussions 

 

Topics:

  • Clawback – outlook for 2014
  • Clawback related case-law and administrative practices
  • Compensated medicine debt: 1.3 billion euro
  • Medicine’s prices dynamic. Local vs. imports
  • Pharmaceutical market perspectives

 

Moderator:

  • Valeriu Stoica, Founding Partner, STOICA & Asociaţii

 

Proposed speakers:

  • Adrian Pană, Secretary of State, Ministry of Health
  • Cristian Buşoi, President, National Health Insurance House
  • Amelia Dinu, General Manager, BBraun Medical Romania
  • Dragoş Bogdan, Partner, STOICA & Asociaţii
  • Petru Crăciun, General Manager, Cegedim
  • Laurentiu Mihai, Executive Director, Romanian Generic Medicines Manufacturers Association (APMGR)
  • Luca Visini, CEO, Ely Lilly, ARPIM Member

 

17.30 – 18.00 Final Questions & Answers

18.00 – 19.00 Networking Cocktail 

 

 ATTENDANCE BY INVITATION ONLY

Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue